The objective of this study was to detect the incidence of BAALC and ERG in a group of denovo AML patients with abnormal karyotype in comparison to normal individuals, their levels and distribution among AML FAB subtypes as well as to study their impact on the disease outcome and reliability in detection of minimal residual disease in relation to the cytogenetic markers. The gene discussed is ERG; the disease is acute myeloid leukemia.